http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20746291

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Journal Article|Research Support, Non-U.S. Gov't
endingPage 306
issn 0002-9394
issueIdentifier 2
pageRange 298-306
publicationName American Journal of Ophthalmology
startingPage 298
bibliographicCitation Spaide RF, Chang LK, Klancnik JM, Yannuzzi LA, Sorenson J, Slakter JS, Freund KB, Klein R. Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion. American Journal of Ophthalmology. 2009 Feb;147(2):298–306. doi: 10.1016/j.ajo.2008.08.016.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76d45bc0f11ee69885cc75cceda7bccc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_081d6d69766f9a84d0d212b01155126a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c3155cec592e1550222c908116615d0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbcaa3f162782f9a4299aca8493880fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afa8b4d819f9c0c54167be51f07e73cf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c2fe959a17601c678bedf3b0acb69bf8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5498fe437b5e03ae7c8e7d117683f482
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7888-9773
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_255cd8c4f87977f8d3dce28923f800b2
date 200902
identifier https://doi.org/10.1016/j.ajo.2008.08.016
https://pubmed.ncbi.nlm.nih.gov/18929354
isPartOf https://portal.issn.org/resource/ISSN/0002-9394
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/441
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Prospective Study of Intravitreal Ranibizumab as a Treatment for Decreased Visual Acuity Secondary to Central Retinal Vein Occlusion
discusses http://id.nlm.nih.gov/mesh/M0356369
http://id.nlm.nih.gov/mesh/M0328153
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0481787
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D014786Q000188
http://id.nlm.nih.gov/mesh/D014792Q000187
http://id.nlm.nih.gov/mesh/D020533Q000627
http://id.nlm.nih.gov/mesh/D012170Q000188
http://id.nlm.nih.gov/mesh/D000911Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D020533Q000009
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D041623
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D014822
http://id.nlm.nih.gov/mesh/D011446
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D005451
http://id.nlm.nih.gov/mesh/D061067
http://id.nlm.nih.gov/mesh/D014786Q000503
http://id.nlm.nih.gov/mesh/D000911Q000009
http://id.nlm.nih.gov/mesh/D014792Q000502
http://id.nlm.nih.gov/mesh/D007267
http://id.nlm.nih.gov/mesh/D012170Q000150
http://id.nlm.nih.gov/mesh/D042461Q000037
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D012170Q000503
http://id.nlm.nih.gov/mesh/D000069579
http://id.nlm.nih.gov/mesh/D014786Q000209
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D005500
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7218
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8398
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9091
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9090
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31307
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638015
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6746

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127977452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128684338

Total number of triples: 71.